MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$119,591K
Net Income
-$83,420K
Net Profit Margin
-69.75%
EPS
-$1.14
Unit: Thousand (K) dollars
Revenue Breakdown
    • Xacduro
    • Giapreza
    • License And Other Revenue
    • Others
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
119,591
97,994
114,613
107,800
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)
22,349
15,607
32,309*
25,643
Cost of license revenue-License
-
-
0*
-
Amortization of acquired intangible assets
6,626
6,554
6,637
6,618
Gross profit
90,616
75,833
75,667
75,539
Selling, general and administrative
34,571
32,438
32,124
27,291
Research and development
5,190
5,241
4,555
13,670
Total operating expenses
39,761
37,679
36,679
40,961
Income from operations
50,855
38,154
38,988
34,578
Changes in fair values of equity method investments, net
-131,834
157,650
111,149
30,751
Changes in fair values of equity and long-term investments, net
-29,153
33,575
42,669
31,510
Interest and dividend income
7,599
10,987
6,151
5,472
Interest expense
5,472
5,437
3,309
4,015
Other expense, net
-15
-366
-612
-479
Income (loss) before income taxes
-108,020
234,563
195,036
97,817
Income tax benefit (expense), net
-24,600
47,968
30,883
7,909
Net income (loss) and comprehensive income (loss)
-83,420
186,595
164,153
89,908
Basic EPS
-1.14
2.52
2.19
1.3
Diluted EPS
-1.14
2.22
1.535
1.08
Basic Average Shares
73,421,000
74,160,000
74,948,000
69,058,000
Diluted Average Shares
73,421,000
84,849,000
106,915,000
84,964,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Total royalties$59,790K Xacduro$22,382K Giapreza$22,299K Xerava$6,739K ZEVTERA$351K Royalty$56,334K Product$51,771K License And OtherRevenue$11,486K Less amortization ofcapitalized fees paid$3,456K Total revenue$119,591K (19.25%↑ Y/Y)Net income (loss)and comprehensive...-$83,420K (-230.98%↓ Y/Y)Income tax benefit(expense), net-$24,600K (-376.09%↓ Y/Y)Gross profit$90,616K (8.98%↑ Y/Y)Cost of products sold(inclusive of amortization...$22,349K (111.04%↑ Y/Y)Amortization of acquiredintangible assets$6,626K (1.21%↑ Y/Y)Income (loss) beforeincome taxes-$108,020K (-248.79%↓ Y/Y)Income from operations$50,855K (4.32%↑ Y/Y)Interest and dividendincome$7,599K (54.29%↑ Y/Y)Total operatingexpenses$39,761K (15.60%↑ Y/Y)Changes in fair values ofequity method...-$131,834K (-1107.75%↓ Y/Y)Changes in fair values ofequity and long-term...-$29,153K (-358.45%↓ Y/Y)Interest expense$5,472K (17.35%↑ Y/Y)Other expense, net-$15K (98.07%↑ Y/Y)Selling, general andadministrative$34,571K (30.89%↑ Y/Y)Research and development$5,190K (-34.99%↓ Y/Y)

Innoviva, Inc. (INVA)

Innoviva, Inc. (INVA)